Mirsaeedi-Farahani Keyvan reported ADGM

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0002031256-26-000002

Machine-readable

Structured copy

Timestamps

Event (reported)

Jun 16, 2026

Published

Aug 12, 2026

Ingested by INSIDER

Nov 5, 02:23 UTC

Last re-read

Nov 5, 02:23 UTC

Extracted facts

Filer

Mirsaeedi-Farahani Keyvan

Role

Director

Transaction

Grant or awardAs filed: “A”

Asset

Adagio Medical Holdings, Inc. — Non-qualified stock option (right to buy)

Ticker

ADGM

Shares

30.0K

Price per share

$0

Execution date (reported)

Jun 16, 2026

Owned after transaction

30.0K shares

Days from execution to publication

57

What this establishes

Mirsaeedi-Farahani Keyvan filed this Form 4 reporting a grant or award of ADGM on Jun 16, 2026. It became public on Aug 12, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director

Mirsaeedi-Farahani Keyvancik:0002031256

Issuer

Adagio Medical Holdings, Inc.cik:0002006986

Revision history · 0

No field has changed since this record was first ingested.